Indaptus Therapeutics, Inc. (INDP) Operating cash flow 2020–2025
Indaptus Therapeutics, Inc. (INDP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$14.8MFY2025 · since FY2020: -$3.3M → -$14.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.8M | -20.3% |
| FY2024 | -$12.3M | +8.1% |
| FY2023 | -$13.4M | -2.5% |
| FY2022 | -$13.1M | -15.8% |
| FY2021 | -$11.3M | -239.6% |
| FY2020 | -$3.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice